Skip to main content

Latest SEC Filings — Page 128

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Super Group Declares Regular Quarterly Cash Dividend of 5 Cents Per Share
Form 6-KSGHC · Form 6-K · 2026-06-11
Vera Bradley Reports First Revenue Growth Since FY22, Beats Q1 Estimates, Raises Guidance
ProForm 8-KVRA · Form 8-K · 2026-06-11
J.W. Mays Reports Significant Q3 Loss and Revenue Decline Amid Tenant Issues, Secures New Loans
ProForm 10-QMAYS · Form 10-Q · 2026-06-11
Prairie Operating Co. Reaffirms $475M Credit Facility, Amends Preferred Stock & Warrants
ProForm 8-KPROP · Form 8-K · 2026-06-11
MINISO Repurchases $19.66 Million in Shares Over Three Days
Form 6-KMNSO · Form 6-K · 2026-06-11
RMG ML Sports Holdings Finalizes $200M IPO with Significant Shareholder Dilution
ProForm 424B4SHOTU · Form 424B4 · 2026-06-11
Atossa Therapeutics Secures $4.1M in Registered Direct Offering Priced Above Market, Plus Warrants
ProForm 8-KATOS · Form 8-K · 2026-06-11
QTREX Quantum Regains Full Nasdaq Compliance, Eliminating Delisting Risk
ProForm 6-KQTEX · Form 6-K · 2026-06-11
Arrow Financial Secures All Approvals for Adirondack Bancorp Merger, Sets July 1 Closing
ProForm 8-KAROW · Form 8-K · 2026-06-11
Novartis's FSHD drug (del-brax) meets Phase I/II biomarker endpoints, advancing potential first-in-class treatment.
ProForm 6-KNVS · Form 6-K · 2026-06-11
Eaton's Mobility Group to Combine with Dana, Forming New $11B Revenue Entity
ProForm 425ETN · Form 425 · 2026-06-11
Eaton's Mobility Group to Combine with Dana Inc in Definitive Agreement
ProForm 425ETN · Form 425 · 2026-06-11
Summit Therapeutics Withdraws $500M Public Offering Due to Market Conditions
ProForm 8-KSMMT · Form 8-K · 2026-06-11
SPAC Merger with Exascale Labs Proceeds Amidst Going Concern Warning and Unsecured Financing
ProForm S-4/ABCAR · Form S-4/A · 2026-06-11
Divesiran Phase 1 Data Shows Durable Efficacy, Quality-of-Life Improvements in Polycythemia Vera
ProForm 8-KSLN · Form 8-K · 2026-06-11
Aurora Cannabis Reports Record Annual Medical Revenue & EBITDA, but Forecasts FY27 Revenue Decline and Lower EBITDA
ProForm 6-KACB · Form 6-K · 2026-06-11
Chairman Erik Prince Outlines M&A-Driven Growth Strategy, Explains $150M+ Equity Facility
ProForm FWPSWMR · Form FWP · 2026-06-11
NOVONIX Delivers First North American Mass Production AAM Sample to Panasonic
ProForm 6-KNVX · Form 6-K · 2026-06-11
Driven Brands Reports Solid Q1, Reaffirms Guidance, Expects Nasdaq Compliance Today
ProForm 8-KDRVN · Form 8-K · 2026-06-11
McGraw Hill Reports Profit Turnaround, Significant Debt Reduction, and $50M Share Buyback
ProForm 10-KMH · Form 10-K · 2026-06-11
Xeris Biopharma Reduces Convertible Debt by $23M, Issues Shares
ProForm 8-KXERS · Form 8-K · 2026-06-11
AC Immune Secures $4M Grant to Extend Parkinson's Trial
Form 6-KACIU · Form 6-K · 2026-06-11
McGraw Hill Reports FY2026 Profit Turnaround, Strong FY2027 Guidance, and $50M Share Repurchase
ProForm 8-KMH · Form 8-K · 2026-06-11
Kanzhun Repurchases $4M in Shares at 50% Discount to Market Price
ProForm 6-KBZ · Form 6-K · 2026-06-11
Climb Bio Reports Positive Phase 1b Data for Budoprutug in ITP
ProForm 8-KCLYM · Form 8-K · 2026-06-11
Shareholders Elect Directors with Significant Dissent
Form 8-KBMEA · Form 8-K · 2026-06-11
Elemental Royalty Corp Announces Significant 5% Share Buyback Program
ProForm 6-KELE · Form 6-K · 2026-06-11
Nurix Therapeutics Reports Strong Phase 1b Data for BTK Degrader Bexobrutideg, Supporting Phase 3 & Roche Collaboration
ProForm 8-KNRIX · Form 8-K · 2026-06-11
Lovesac Reports Wider Q1 Loss, Flat Sales, and Significant Cash Burn
ProForm 10-QLOVE · Form 10-Q · 2026-06-11
Aurora Cannabis Reports Material Weakness in Internal Controls, Posts Significant Annual Loss, and Details Strategic Shifts
ProForm 40-FACB · Form 40-F · 2026-06-11